Medtronic plc (FRA:2M6)

Market Cap	105.40B -6.6%
Revenue (ttm)	30.18B +6.9%
Net Income	3.92B +8.3%
EPS	3.04 +9.1%
Shares Out	n/a
PE Ratio	26.86
Forward PE	16.25
Dividend	2.47 (3.00%)
Ex-Dividend Date	Dec 26, 2025

Volume	616
Average Volume	1,042
Open	83.09
Previous Close	82.80
Day's Range	82.08 - 83.25
52-Week Range	68.50 - 91.45
Beta	n/a
RSI	41.22
Earnings Date	Feb 17, 2026

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2M6

Financial Performance

In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD